Standout Papers

Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections... 2008 2026 2014 2020 425
  1. Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study (2008)
    Edward Keystone, Mark C. Genovese et al. Annals of the Rheumatic Diseases

Immediate Impact

4 by Nobel laureates 10 from Science/Nature 67 standout
Sub-graph 1 of 22

Citing Papers

Therapeutic advances in rheumatoid arthritis
2024 Standout
Persistent physical symptoms: definition, genesis, and management
2024 Standout
7 intermediate papers

Works of J Pazdur being referenced

The relationship between work, mental health, physical health, and fatigue in patients with rheumatoid arthritis: A cross-sectional study
2017
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
2008 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
J Pazdur 619 29 211 293 22 896
Z Domljan 652 55 296 299 18 1.1k
J. S. Smolen 567 132 182 217 23 925
Antonio Sánchez 666 76 243 333 19 975
Sarah Bingham 538 72 289 252 30 994
A. Krabben 669 24 109 163 26 841
Melek Güler-Yüksel 828 20 132 193 19 963
Herbert Kellner 746 43 518 303 37 1.2k
H. R. Van Den Brink 972 29 163 345 14 1.2k
M. C. Genovese 621 32 223 314 36 821
Carl Orr 481 62 366 160 23 984

All Works

Loading papers...

Rankless by CCL
2026